The Annals Summaries of the Latest Medical Research!
home help contact us subscription past issues search current issue
QUICK SEARCH:   [advanced]


     

The Annals of Pharmacotherapy: Vol. 34, No. 12, pp. 1432-1439. DOI 10.1345/aph.10124
© 2000 Harvey Whitney Books Company.
This Article
Right arrow PDF
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Articles Ahead of Print
Right arrow [Order Reprint]
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sotiriou, C.
Right arrow Articles by Cheng, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sotiriou, C.
Right arrow Articles by Cheng, J.

Research Articles

Beneficial effects of statins in coronary artery disease--beyond lowering cholesterol

CG Sotiriou and JW Cheng

OBJECTIVE: To review the benefits of statins in coronary artery disease management beyond their cholesterol-lowering effects. DATA SOURCES: A MEDLINE search (1966-May 2000) was conducted using the following terms: lovastatin, pravastatin, simvastatin, atorvastatin, fluvastatin, cerivastatin, endothelium, plaque stabilization, antithrombotic effects. STUDY SELECTION: English-language human studies and case reports. DATA EXTRACTION: Studies published demonstrating other mechanisms of statins' clinical beneficial effects were evaluated and reviewed. DATA SYNTHESIS: The understanding of the pharmacologic effects of statins has led to the realization that the benefits of these agents extend beyond simply lowering cholesterol. These properties include beneficial effects on vessel endothelial tissue; decreased low-density lipoprotein oxidation and inflammation; ability to stabilize atherosclerotic plaques and perhaps promote regression; proliferative effects on smooth-muscle growths, possibly strengthening atherosclerotic plaques; antithrombotic effects by inhibiting platelet aggregation and stimulation of fibrinolytic factors; and improvement of blood viscosity and flow. With these actions, statins may benefit the situation of long-term atherosclerotic plaque formation and the setting of acute coronary syndrome. CONCLUSIONS: Further large-scale studies are needed to determine the clinical importance and validity of these postulated beneficial effects of statins.


This article has been cited by other articles:


Home page
 BMJHome page
G. F M Strippoli, S. D Navaneethan, D. W Johnson, V. Perkovic, F. Pellegrini, A. Nicolucci, and J. C Craig
Effects of statins in patients with chronic kidney disease: meta-analysis and meta-regression of randomised controlled trials
BMJ, March 22, 2008; 336(7645): 645 - 651.
[Abstract] [Full Text] [PDF]

Home page
 Arch Intern MedHome page
V. L. Serebruany, M. G. Midei, A. I. Malinin, B. R. Oshrine, D. R. Lowry, D. C. Sane, J.-F. Tanguay, S. R. Steinhubl, P. B. Berger, C. M. O'Connor, et al.
Absence of Interaction Between Atorvastatin or Other Statins and Clopidogrel: Results From the Interaction Study
Arch Intern Med, October 11, 2004; 164(18): 2051 - 2057.
[Abstract] [Full Text] [PDF]

Home page
 ANN INTERN MEDHome page
S. Vijan and R. A. Hayward
Pharmacologic Lipid-Lowering Therapy in Type 2 Diabetes Mellitus: Background Paper for the American College of Physicians
Ann Intern Med, April 20, 2004; 140(8): 650 - 658.
[Abstract] [Full Text] [PDF]

Home page
 The Annals of PharmacotherapyHome page
V. F Mauro and C. E Tuckerman
Ezetimibe for Management of Hypercholesterolemia
Ann. Pharmacother., June 1, 2003; 37(6): 839 - 848.
[Abstract] [Full Text] [PDF]


homecopy help contact us subscription past issues search current issue
Copyright © 2000 by Harvey Whitney Books Company.